{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:03:26Z","timestamp":1771603406703,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1403-3-107-74077"],"award-info":[{"award-number":["1403-3-107-74077"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-026-03083-3","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:46:42Z","timestamp":1769687202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNAs as potential prognostic biomarkers in acute lymphoblastic leukemia: a systematic review, meta-analysis, and bioinformatics study"],"prefix":"10.1186","volume":"15","author":[{"given":"Samaneh","family":"Toutounchian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyarash","family":"Behboodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Alinejadfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmida","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maedeh","family":"Mohaghegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasra","family":"Izadpanahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Mohagheghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmeh","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Eghbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-2729","authenticated-orcid":false,"given":"Zahra","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"6","key":"3083_CR1","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6): e577-e.","journal-title":"Blood Cancer J"},{"issue":"4","key":"3083_CR2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.hoc.2009.04.009","volume":"23","author":"M Onciu","year":"2009","unstructured":"Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(4):655\u201374.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"15","key":"3083_CR3","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/cncr.29383","volume":"121","author":"E Jabbour","year":"2015","unstructured":"Jabbour E, O\u2019Brien S, Konopleva M, Kantarjian H. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015;121(15):2517\u201328.","journal-title":"Cancer"},{"issue":"6","key":"3083_CR4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.26156","volume":"96","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Jabbour E, Short NJ, Jain N, Ravandi F, Pui CH, et al. Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980\u20132017. Am J Hematol. 2021;96(6):650\u20138.","journal-title":"Am J Hematol"},{"issue":"3","key":"3083_CR5","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","volume":"20","author":"DT Teachey","year":"2019","unstructured":"Teachey DT, Pui C-H. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol. 2019;20(3):e142\u201354.","journal-title":"Lancet Oncol"},{"issue":"10","key":"3083_CR6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jamaoncol.2018.1915","volume":"4","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Pui C-H, Kantarjian H. Progress and innovations in the management of adult acute lymphoblastic leukemia. JAMA Oncol. 2018;4(10):1413\u201320.","journal-title":"JAMA Oncol"},{"issue":"9","key":"3083_CR7","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"C-H Pui","year":"2004","unstructured":"Pui C-H, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children\u2019s Research Hospital. Blood. 2004;104(9):2690\u20136.","journal-title":"Blood"},{"key":"3083_CR8","doi-asserted-by":"crossref","unstructured":"Moradi Z, Toutounchian S, Eghbali Z, Barzegar M, Mohammadi D, Salabat D, et al. Incidence and risk factors of hypothyroidism in patients with hematological malignancies compared to healthy population: a systematic review and meta-analysis. BMC Cancer. 2025;25(1):1788.","DOI":"10.1186\/s12885-025-15228-z"},{"key":"3083_CR9","doi-asserted-by":"publisher","unstructured":"Moradi Z, Toutounchian S, Akhiani A, Razaghi H, Mamdooh MA, Bagheri P, et al.\u00a0Increased incidence of diabetes mellitus in hematological malignancies: a systematic review and meta-analysis. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-026-15644-9.","DOI":"10.1186\/s12885-026-15644-9"},{"key":"3083_CR10","doi-asserted-by":"publisher","unstructured":"Salabat D, Toutounchian S, Salabat D, Babaei A, Malekshahi M, Barkhordar M, Salehi Z.\u00a0The impact of anxiety and depression on hematologic malignancy outcomes: a systematic review and meta-analysis. BMC Cancer. 2025;25(1). https:\/\/doi.org\/10.1186\/s12885-025-15161-1.","DOI":"10.1186\/s12885-025-15161-1"},{"key":"3083_CR11","doi-asserted-by":"crossref","first-page":"109995","DOI":"10.1016\/j.cellsig.2021.109995","volume":"83","author":"M Budakoti","year":"2021","unstructured":"Budakoti M, Panwar AS, Molpa D, Singh RK, B\u00fcsselberg D, Mishra AP, et al. Micro-RNA: the darkhorse of cancer. Cell Signal. 2021;83:109995.","journal-title":"Cell Signal"},{"key":"3083_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199\u2013227.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"3083_CR13","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.18632\/aging.102813","volume":"12","author":"J Liu","year":"2020","unstructured":"Liu J, Chen Z, Cui Y, Wei H, Zhu Z, Mao F, et al. Berberine promotes XIAP-mediated cells apoptosis by upregulation of miR-24-3p in acute lymphoblastic leukemia. Aging (Albany NY). 2020;12(4):3298.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"3083_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050895","volume":"7","author":"KA Scheibner","year":"2012","unstructured":"Scheibner KA, Teaboldt B, Hauer MC, Chen X, Cherukuri S, Guo Y, et al. MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3\u22123\u03b8. PLoS One. 2012;7(12):e50895.","journal-title":"PLoS One"},{"issue":"4","key":"3083_CR15","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3892\/or.2015.3787","volume":"33","author":"J Organista-Nava","year":"2015","unstructured":"Organista-Nava J, G\u00f3mez-G\u00f3mez Y, Illades-Aguiar B, Del Carmen A-R, Saavedra-Herrera MV, Rivera-Ram\u00edrez AB, et al. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia. Oncol Rep. 2015;33(4):1639\u201349.","journal-title":"Oncol Rep"},{"issue":"6","key":"3083_CR16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/bjc.2017.256","volume":"117","author":"D Piatopoulou","year":"2017","unstructured":"Piatopoulou D, Avgeris M, Marmarinos A, Xagorari M, Baka M, Doganis D, et al. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. Br J Cancer. 2017;117(6):801\u201312.","journal-title":"Br J Cancer"},{"issue":"5","key":"3083_CR17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3324\/haematol.2010.026138","volume":"96","author":"D Schotte","year":"2011","unstructured":"Schotte D, De Menezes RX, Moqadam FA, Khankahdani LM, Lange-Turenhout E, Chen C, et al. MicroRNA\u00a0characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011;96(5):703.","journal-title":"Haematologica"},{"key":"3083_CR18","doi-asserted-by":"crossref","unstructured":"So AY-L, Sookram R, Chaudhuri AA, Minisandram A, Cheng D, Xie C, et al. Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. Blood, J Am Soc Hematol. 2014;124(9):1502\u201312.","DOI":"10.1182\/blood-2014-02-553842"},{"issue":"10","key":"3083_CR19","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/leu.2012.95","volume":"26","author":"M Puissegur","year":"2012","unstructured":"Puissegur M, Eichner R, Quelen C, Coyaud E, Mari B, Lebrigand K, et al. B-cell regulator of immunoglobulin heavy-chain transcription (Bright)\/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells. Leukemia. 2012;26(10):2224\u201332.","journal-title":"Leukemia"},{"key":"3083_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.critrevonc.2019.02.008","volume":"136","author":"WM Rashed","year":"2019","unstructured":"Rashed WM, Hammad AM, Saad AM, Shohdy KS. Microrna as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations. Crit Rev Oncol Hematol. 2019;136:70\u20138.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"16","key":"3083_CR21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163976","volume":"14","author":"I Kyriakidis","year":"2022","unstructured":"Kyriakidis I, Kyriakidis K, Tsezou A. Micrornas and the diagnosis of childhood acute lymphoblastic leukemia: systematic review, meta-analysis and re-analysis with novel small RNA-seq tools. Cancers (Basel). 2022;14(16):3976.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"3083_CR22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12253-014-9861-z","volume":"21","author":"K Nemes","year":"2015","unstructured":"Nemes K, Cs\u00f3ka M, Nagy N, M\u00e1rk \u00c1, V\u00e1radi Z, Dank\u00f3 T, et al. Expression of certain leukemia\/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia. Pathol Oncol Res. 2015;21(3):597\u2013604.","journal-title":"Pathol Oncol Res"},{"issue":"6","key":"3083_CR23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4161\/cc.9.6.11011","volume":"9","author":"A Kotani","year":"2010","unstructured":"Kotani A, Ha D, Schotte D, den Boer ML, Armstrong SA, Lodish HF. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells. Cell Cycle. 2010;9(6):1037\u201342.","journal-title":"Cell Cycle"},{"key":"3083_CR24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10555-019-09826-0","volume":"38","author":"WM Rashed","year":"2019","unstructured":"Rashed WM, Hamza MM, Matboli M, Salem SI. Microrna as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review. Cancer Metastasis Rev. 2019;38:771\u201382.","journal-title":"Cancer Metastasis Rev"},{"key":"3083_CR25","doi-asserted-by":"crossref","unstructured":"Sabarimurugan S, Kumarasamy C, Royam Madhav M, Samiappan S, Jayaraj R. The significance of mirnas as a prognostic biomarker for survival outcome in T cell\u2013acute lymphoblastic leukemia patients: a systematic review and meta-analysis. Cancer Manag Res. 2020;12:819\u201339.","DOI":"10.2147\/CMAR.S200687"},{"issue":"4","key":"3083_CR26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","volume":"5","author":"C Luchini","year":"2017","unstructured":"Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal. 2017;5(4):80\u20134.","journal-title":"World J Meta-Anal"},{"key":"3083_CR27","unstructured":"Wells G SB, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2013 [Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"10","key":"3083_CR28","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.21037\/jtd-20-1739","volume":"12","author":"AM Jiang","year":"2020","unstructured":"Jiang AM, Zhao R, Liu N, Ma YY, Ren MD, Tian T, et al. The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and its influencing factors: a meta-analysis of observational studies. J Thorac Dis. 2020;12(10):5718\u201328.","journal-title":"J Thorac Dis"},{"issue":"1","key":"3083_CR29","volume":"7","author":"H Han","year":"2017","unstructured":"Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7(1):44877.","journal-title":"Sci Rep"},{"issue":"1","key":"3083_CR30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJNM, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-meier survival curves. BMC Med Res Methodol. 2012;12(1):9.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"3083_CR31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jrsm.1362","volume":"10","author":"R Saluja","year":"2019","unstructured":"Saluja R, Cheng S, Delos Santos KA, Chan KKW. Estimating hazard ratios from published Kaplan-meier survival curves: a methods validation study. Res Synth Methods. 2019;10(3):465\u201375.","journal-title":"Res Synth Methods"},{"issue":"D1","key":"3083_CR32","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang HY, Lin YC, Cui S, Huang Y, Tang Y, Xu J, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(D1):D222\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3083_CR33","doi-asserted-by":"crossref","unstructured":"Bailur JK, McCachren SS, Pendleton K, Vasquez JC, Lim HS, Duffy A, et al. Risk-associated alterations in marrow T cells in pediatric leukemia. JCI Insight. 2020;5(16):e140179.","DOI":"10.1172\/jci.insight.140179"},{"issue":"1","key":"3083_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39152-z","volume":"13","author":"SS Bhasin","year":"2023","unstructured":"Bhasin SS, Thomas BE, Summers RJ, Sarkar D, Mumme H, Pilcher W, et al. Pediatric T-cell acute lymphoblastic leukemia blast signature and mrd associated immune environment changes defined by single cell transcriptomics analysis. Sci Rep. 2023;13(1):12556.","journal-title":"Sci Rep"},{"issue":"9","key":"3083_CR35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.leukres.2008.12.015","volume":"33","author":"T Kaddar","year":"2009","unstructured":"Kaddar T, Chien W, Bertrand Y, Pages M, Rouault J, Salles G, et al. Prognostic value of mir-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation. Leuk Res. 2009;33(9):1217\u201323.","journal-title":"Leuk Res"},{"issue":"3","key":"3083_CR36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcmd.2009.12.010","volume":"44","author":"Y Wang","year":"2010","unstructured":"Wang Y, Li Z, He C, Wang D, Yuan X, Chen J, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis. 2010;44(3):191\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"3083_CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bjh.12489","volume":"163","author":"J Yan","year":"2013","unstructured":"Yan J, Jiang N, Huang G, Tay JL, Lin B, Bi C, et al. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. Br J Haematol. 2013;163(1):93\u2013103.","journal-title":"Br J Haematol"},{"issue":"1","key":"3083_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/16078454.2020.1860187","volume":"26","author":"C Liang","year":"2021","unstructured":"Liang C, Li Y, Wang L-N, Zhang X-L, Luo J-S, Peng C-J, et al. Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238. Hematology. 2021;26(1):16\u201325.","journal-title":"Hematology"},{"issue":"1","key":"3083_CR39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/10428194.2013.790023","volume":"55","author":"F Sugita","year":"2014","unstructured":"Sugita F, Maki K, Nakamura Y, Sasaki K, Mitani K. Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia. Leuk Lymphoma. 2014;55(1):78\u201386.","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"3083_CR40","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood.V128.22.1736.1736","volume":"128","author":"S Avigad","year":"2016","unstructured":"Avigad S, Shichrur K, Elitzur S, Gilad G, Barzilai S, Avrahami G, et al. Mir expression profile of peripheral blood lymphocytes predicts relapse in pediatric acute lymphoblastic leukemia. Blood. 2016;128(22):1736.","journal-title":"Blood"},{"issue":"6","key":"3083_CR41","first-page":"8072","volume":"14","author":"Y Mei","year":"2017","unstructured":"Mei Y, Li Z, Zhang Y, Zhang W, Hu H, Zhang P, et al. Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia. Oncol Lett. 2017;14(6):8072\u20137.","journal-title":"Oncol Lett"},{"issue":"4","key":"3083_CR42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/00365513.2023.2191335","volume":"83","author":"X Chu","year":"2023","unstructured":"Chu X, Wu D, Zhang C, Hu S. Expression pattern of miR-16-2=\u22123p and its prognostic values on pediatric acute lymphoblastic leukemia. Scand J Clin Lab Invest. 2023;83(4):207\u201311.","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"3083_CR43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/cas.12370","volume":"105","author":"Y Mei","year":"2014","unstructured":"Mei Y, Gao C, Wang K, Cui L, Li W, Zhao X, et al. Effect of micro RNA\u2010210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia. Cancer Sci. 2014;105(4):463\u201372.","journal-title":"Cancer Sci"},{"issue":"1","key":"3083_CR44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/16078454.2020.1843753","volume":"25","author":"NM Hassan","year":"2020","unstructured":"Hassan NM, Refaat LA, Ismail GN, Abdellateif M, Fadel SA, AbdelAziz RS. Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic leukemia. Hematology. 2020;25(1):405\u201313.","journal-title":"Hematology"},{"issue":"4","key":"3083_CR45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/leu.2011.273","volume":"26","author":"M Lv","year":"2012","unstructured":"Lv M, Zhang X, Jia H, Li D, Zhang B, Zhang H, et al. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-\u03b1 and cAMP\/PKA pathways. Leukemia. 2012;26(4):769\u201377.","journal-title":"Leukemia"},{"issue":"9","key":"3083_CR46","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1080\/10428194.2017.1283028","volume":"58","author":"G Zhou","year":"2017","unstructured":"Zhou G, Cao Y, Dong W, Lin Y, Wang Q, Wu W, et al. The clinical characteristics and prognostic significance of AID, miR-181b, and miR-155 expression in adult patients with de novo B-cell acute lymphoblastic leukemia. Leukemia Lymphoma. 2017;58(9):2118\u201326.","journal-title":"Leukemia Lymphoma"},{"issue":"4","key":"3083_CR47","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1002\/jcb.27918","volume":"120","author":"N El\u2010Khazragy","year":"2019","unstructured":"El\u2010Khazragy N, Noshi MA, Abdel\u2010Malak C, Zahran RF, Swellam M. miRNA\u2010155 and miRNA\u2010181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia. J Cell Biochem. 2019;120(4):6315\u201321.","journal-title":"J Cell Biochem"},{"issue":"7","key":"3083_CR48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10245332.2017.1292204","volume":"22","author":"HA Labib","year":"2017","unstructured":"Labib HA, Elantouny NG, Ibrahim NF, Alnagar AA. Upregulation of microrna-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia. Hematology. 2017;22(7):392\u20137.","journal-title":"Hematology"},{"issue":"24","key":"3083_CR49","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1093\/hmg\/ddr428","volume":"20","author":"B-W Han","year":"2011","unstructured":"Han B-W, Feng D-D, Li Z-G, Luo X-Q, Zhang H, Li X-J, et al. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet. 2011;20(24):4903\u201315.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"3083_CR50","first-page":"4764","volume":"12","author":"Y-H Chang","year":"2022","unstructured":"Chang Y-H, Jou S-T, Yen C-T, Lin C-Y, Yu C-H, Chang S-K, et al. A microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols. Am J Cancer Res. 2022;12(10):4764.","journal-title":"Am J Cancer Res"},{"key":"3083_CR51","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9337","volume":"8","author":"S Long","year":"2020","unstructured":"Long S, Ren D, Zhong F, Niu Y, Qin X, Mu D, et al. Reversal of glucocorticoid resistance in acute lymphoblastic leukemia cells by miR-145. PeerJ. 2020;8: e9337.","journal-title":"PeerJ"},{"key":"3083_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2162-3619-2-10","volume":"2","author":"HL Gimenes-Teixeira","year":"2013","unstructured":"Gimenes-Teixeira HL, Lucena-Araujo AR, Dos Santos GA, Zanette DL, Scheucher PS, Oliveira LC, et al. Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Exp Hematol Oncol. 2013;2:1\u20138.","journal-title":"Exp Hematol Oncol"},{"issue":"8","key":"3083_CR53","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/bjc.2013.562","volume":"109","author":"X Li","year":"2013","unstructured":"Li X, Luo X, Han B, Duan F, Wei P, Chen Y. MicroRNA-100\/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R\/mTOR signalling pathways. Br J Cancer. 2013;109(8):2189\u201398.","journal-title":"Br J Cancer"},{"issue":"4","key":"3083_CR54","first-page":"358","volume":"8","author":"MA Esmaili","year":"2020","unstructured":"Esmaili MA, Kazemi A, Zaker F, Faranoush M, Rezvany MR. Effects of reduced Mir-24 expression on plasma methotrexate levels, therapy-related toxicities, and patient outcomes in pediatric acute lymphoblastic leukemia. Rep Biochem Mol Biol. 2020;8(4):358.","journal-title":"Rep Biochem Mol Biol"},{"issue":"1","key":"3083_CR55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/ijo.2014.2415","volume":"45","author":"H Li","year":"2014","unstructured":"Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, et al. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol. 2014;45(1):197\u2013208.","journal-title":"Int J Oncol"},{"key":"3083_CR56","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s13277-015-3951-8","volume":"37","author":"B Yang","year":"2016","unstructured":"Yang B, Huang J, Liu H, Guo W, Li G. MiR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells. Tumor Biol. 2016;37:1771\u20139.","journal-title":"Tumor Biol"},{"key":"3083_CR57","first-page":"1","volume":"20","author":"W Du","year":"2019","unstructured":"Du W, Tang H, Lei Z, Zhu J, Zeng Y, Liu Z, et al. miR-335-5p inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition in non-small cell lung cancer via ROCK1. Respir Res. 2019;20:1\u201311.","journal-title":"Respir Res"},{"issue":"3","key":"3083_CR58","first-page":"1120","volume":"24","author":"L Wang","year":"2019","unstructured":"Wang L, Zhao Y, Xu M, Zhou F, Yan J. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer. J Buon. 2019;24(3):1120\u20137.","journal-title":"J Buon"},{"issue":"3","key":"3083_CR59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1309\/AJCPLYTZGB54ISZC","volume":"141","author":"J Cao","year":"2014","unstructured":"Cao J, Cai J, Huang D, Han Q, Chen Y, Yang Q, et al. MiR-335 represents an independent prognostic marker in epithelial ovarian cancer. Am J Clin Pathol. 2014;141(3):437\u201342.","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"3083_CR60","first-page":"6213","volume":"7","author":"B-J Zhang","year":"2014","unstructured":"Zhang B-J, Gong H-Y, Zheng F, Liu D-J, Liu H-X. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2014;7(9):6213.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"3083_CR61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000430352","volume":"37","author":"L Cui","year":"2015","unstructured":"Cui L, Hu Y, Bai B, Zhang S. Serum miR-335 level is associated with the treatment response to trans-arterial chemoembolization and prognosis in patients with hepatocellular carcinoma. Cell Physiol Biochem. 2015;37(1):276\u201383.","journal-title":"Cell Physiol Biochem"},{"key":"3083_CR62","volume":"10","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Shen P. MiR-335 acts as a tumor suppressor and enhances ionizing radiation-induced tumor regression by targeting ROCK1. Front Oncol. 2020;10:278.","journal-title":"Front Oncol"},{"key":"3083_CR63","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.2147\/OTT.S305098","volume":"14","author":"L Ye","year":"2021","unstructured":"Ye L, Wang F, Wu H, Yang H, Yang Y, Ma Y, et al. Functions and Targets of miR-335 in Cancer. Onco Targets Ther. 2021;14:3335\u201349.","journal-title":"Onco Targets Ther"},{"key":"3083_CR64","doi-asserted-by":"crossref","unstructured":"Palma Flores C, Garc\u00eda-V\u00e1zquez R, Gallardo Rinc\u00f3n D, Ruiz-Garc\u00eda E, Astudillo de la Vega H, Marchat LA, et al. MicroRNAs driving invasion and metastasis in ovarian cancer: opportunities for translational medicine (Review). Int J Oncol. 2017;50(5):1461\u201376.","DOI":"10.3892\/ijo.2017.3948"},{"issue":"2","key":"3083_CR65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/or.2013.2482","volume":"30","author":"J Cao","year":"2013","unstructured":"Cao J, Cai J, Huang D, Han Q, Yang Q, Li T, et al. MiR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w. Oncol Rep. 2013;30(2):701\u20136.","journal-title":"Oncol Rep"},{"issue":"12","key":"3083_CR66","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11121240","volume":"11","author":"E Lombardi","year":"2021","unstructured":"Lombardi E, Almanza G, Kowal K, Valvasori M, Agostini F, Vicinanza C, et al. MiR-335-laden B cell-derived extracellular vesicles promote SOX4-dependent apoptosis in human multiple myeloma cells. J Pers Med. 2021;11(12):1240.","journal-title":"J Pers Med"},{"issue":"2","key":"3083_CR67","first-page":"73","volume":"37","author":"C Yu","year":"2022","unstructured":"Yu C, Ying J, Yu K, Shen W, Jiang M. Circ_0074027 contributes to non-small cell lung cancer progression by upregulating CUL4B expression through miR-335-5p. Cancer Biother Radiopharm. 2022;37(2):73\u201383.","journal-title":"Cancer Biother Radiopharm"},{"key":"3083_CR68","unstructured":"Wang W, Chen L-C, Qian J-Y, Zhang Q. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(22):9829\u201339."},{"key":"3083_CR69","doi-asserted-by":"crossref","unstructured":"Chen L, Shi Y, Li J, Yang X, Li R, Zhou X, et al. LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335\u20133p\/TRAF5 axis. Anticancer Drugs. 2020. Epub ahead of print.","DOI":"10.1097\/CAD.0000000000001001"},{"issue":"9","key":"3083_CR70","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/bbb\/zbab116","volume":"85","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wang X, Wu J, Xiao R, Liu J. MiR-335-3p inhibits cell proliferation and induces cell cycle arrest and apoptosis in acute myeloid leukemia by targeting EIF3E. Biosci Biotechnol Biochem. 2021;85(9):1953\u201361.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"33","key":"3083_CR71","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000986","volume":"94","author":"L Yingchun","year":"2015","unstructured":"Yingchun L, Rong Z, Kun Y, Ying Y, Zhuogang L. Bone marrow microRNA-335 level predicts the chemotherapy response and prognosis of adult acute myeloid leukemia. Medicine (Baltimore). 2015;94(33): e0986.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"3083_CR72","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.18632\/aging.101991","volume":"11","author":"JD Zhou","year":"2019","unstructured":"Zhou JD, Li XX, Zhang TJ, Xu ZJ, Zhang ZH, Gu Y, et al. MicroRNA-335\/ID4 dysregulation predicts clinical outcome and facilitates leukemogenesis by activating PI3K\/Akt signaling pathway in acute myeloid leukemia. Aging (Albany NY). 2019;11(10):3376\u201391.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"3083_CR73","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Zhao J, Shi M, Ding Y, Sun H, Yuan F, et al. Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis. PloS one. 2014;9(2):e89223.","journal-title":"PloS one"},{"issue":"16","key":"3083_CR74","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.3390\/ijms23169375","volume":"23","author":"G Marwarha","year":"2022","unstructured":"Marwarha G, R\u00f8sand \u00d8, Slagsvold KH, H\u00f8ydal MA. GSK3\u03b2 inhibition is the molecular pivot that underlies the Mir-210-induced attenuation of intrinsic apoptosis cascade during hypoxia. Int J Mol Sci. 2022;23(16):9375.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3083_CR75","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.scr.2013.04.005","volume":"11","author":"F Wang","year":"2013","unstructured":"Wang F, Xiong L, Huang X, Zhao T, Wu L-y, Liu Z-h, et al. miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res. 2013;11(1):657\u201367.","journal-title":"Stem Cell Res"},{"key":"3083_CR76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2119\/molmed.2017.00013","volume":"23","author":"L-L Liu","year":"2017","unstructured":"Liu L-L, Li D, He Y-L, Zhou Y-Z, Gong S-H, Wu L-Y, et al. miR-210 protects renal cell against hypoxia-induced apoptosis by targeting HIF-1 alpha. Mol Med. 2017;23:258\u201371.","journal-title":"Mol Med"},{"issue":"1","key":"3083_CR77","volume":"33","author":"Q Qin","year":"2014","unstructured":"Qin Q, Furong W, Baosheng L. Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res. 2014;33(1):50.","journal-title":"J Exp Clin Cancer Res"},{"key":"3083_CR78","doi-asserted-by":"crossref","unstructured":"G\u00f6ktan H, Rahiye Dilhan K, Yilmaz \u015e, Alaylio\u011flu M, Dursun E, AK DG, et al. mir210 and BCL2 expressions in patients with acute myeloid leukemia. 2022.","DOI":"10.14235\/bas.galenos.2021.5447"},{"issue":"2","key":"3083_CR79","volume":"24","author":"C Hu","year":"2021","unstructured":"Hu C, Yan Y, Fu C, Ding J, Li T, Wang S, et al. Effects of miR\u2011210\u20113p on the erythroid differentiation of K562 cells under hypoxia. Mol Med Rep. 2021;24(2):563.","journal-title":"Mol Med Rep"},{"issue":"5","key":"3083_CR80","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1002\/jcb.28017","volume":"120","author":"N El-Khazragy","year":"2019","unstructured":"El-Khazragy N, Elshimy AA, Hassan SS, Matbouly S, Safwat G, Zannoun M, et al. Dysregulation of miR-125b predicts poor response to therapy in pediatric acute lymphoblastic leukemia. J Cell Biochem. 2019;120(5):7428\u201338.","journal-title":"J Cell Biochem"},{"issue":"5","key":"3083_CR81","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3892\/mmr.2014.2011","volume":"9","author":"L Zhou","year":"2014","unstructured":"Zhou L, Bai H, Wang C, Wei D, Qin Y, Xu X. MicroRNA\u2011125b promotes leukemia cell resistance to daunorubicin by inhibiting apoptosis. Mol Med Rep. 2014;9(5):1909\u201316.","journal-title":"Mol Med Rep"},{"key":"3083_CR82","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2147\/CMAR.S232388","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zeng G, Jiang Y. The emerging roles of miR-125b in cancers. Cancer Manag Res. 2020;12:1079\u201388.","journal-title":"Cancer Manag Res"},{"key":"3083_CR83","doi-asserted-by":"crossref","unstructured":"Zhou K, Liu M, Cao Y. New insight into microRNA functions in cancer: oncogene\u2013microRNA\u2013tumor suppressor gene network. Frontiers in Molecular Biosciences. 2017;Volume 4 - 2017.","DOI":"10.3389\/fmolb.2017.00046"},{"issue":"12","key":"3083_CR84","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1080\/15476286.2017.1367888","volume":"14","author":"A Keller","year":"2017","unstructured":"Keller A, Rounge T, Backes C, Ludwig N, Gislefoss R, Leidinger P, et al. Sources to variability in circulating human miRNA signatures. RNA Biol. 2017;14(12):1791\u20138.","journal-title":"RNA Biol"},{"key":"3083_CR85","volume":"39","author":"I Wakabayashi","year":"2024","unstructured":"Wakabayashi I, Marumo M, Ekawa K, Daimon T. Differences in serum and plasma levels of microRNAs and their time-course changes after blood collection. Pract Lab Med. 2024;39: e00376.","journal-title":"Pract Lab Med"},{"key":"3083_CR86","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12: 985363.","journal-title":"Front Oncol"},{"issue":"1","key":"3083_CR87","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s42003-021-02564-6","volume":"4","author":"H Widden","year":"2021","unstructured":"Widden H, Placzek WJ. The multiple mechanisms of MCL1 in the regulation of cell fate. Commun Biol. 2021;4(1):1029.","journal-title":"Commun Biol"},{"issue":"12","key":"3083_CR88","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/bloodadvances.2019001416","volume":"4","author":"DM Moujalled","year":"2020","unstructured":"Moujalled DM, Hanna DT, Hediyeh-Zadeh S, Pomilio G, Brown L, Litalien V, et al. Cotargeting BCL-2 and MCL-1 in high-risk B-ALL. Blood Adv. 2020;4(12):2762\u20137.","journal-title":"Blood Adv"},{"key":"3083_CR89","doi-asserted-by":"crossref","unstructured":"Magliulo D, Bernardi R. Hypoxic stress and hypoxia-inducible factors in leukemias. Frontiers in Oncology. 2022;Volume 12 - 2022.","DOI":"10.3389\/fonc.2022.973978"},{"issue":"1","key":"3083_CR90","doi-asserted-by":"publisher","first-page":"19092","DOI":"10.1038\/s41598-021-98560-1","volume":"11","author":"S Valentin Hansen","year":"2021","unstructured":"Valentin Hansen S, H\u00f8y Hansen M, C\u00e9dile O, M\u00f8ller MB, Haaber J, Abildgaard N, et al. Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4. Sci Rep. 2021;11(1):19092.","journal-title":"Sci Rep"},{"key":"3083_CR91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2019.08.027","volume":"67","author":"CS Moreno","year":"2020","unstructured":"Moreno CS. SOX4: the unappreciated oncogene. Semin Cancer Biol. 2020;67:57\u201364.","journal-title":"Semin Cancer Biol"},{"key":"3083_CR92","doi-asserted-by":"crossref","unstructured":"Podgorica M, Drivet E, Vestb\u00f8stad J, Kvam AK, Wik HS, Munthe L, et al. Azaindole 1, a selective Rock1\/2 kinase inhibitor, induces G2\/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL). Leuk Lymphoma. 2025;66(12):2311\u20135.","DOI":"10.1080\/10428194.2025.2536125"},{"issue":"6","key":"3083_CR93","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/s41375-022-01590-5","volume":"36","author":"ML Oliveira","year":"2022","unstructured":"Oliveira ML, Veloso A, Garcia EG, Iyer S, Pereira C, Barreto VM, et al. Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia. Leukemia. 2022;36(6):1533\u201340.","journal-title":"Leukemia"},{"key":"3083_CR94","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2022.06.089","volume":"621","author":"LT Pham","year":"2022","unstructured":"Pham LT, Peng H, Ueno M, Kohno S, Kasada A, Hosomichi K, et al. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Biochem Biophys Res Commun. 2022;621:74\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3083_CR95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960226","volume":"13","author":"T Sancerni","year":"2022","unstructured":"Sancerni T, Renoult O, Luby A, Caradeuc C, Lenoir V, Croyal M, et al. UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling. Front Immunol. 2022;13: 960226.","journal-title":"Front Immunol"},{"issue":"6","key":"3083_CR96","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.devcel.2021.02.022","volume":"56","author":"W Yang","year":"2021","unstructured":"Yang W, Pang D, Chen M, Du C, Jia L, Wang L, et al. Rheb mediates neuronal-activity-induced mitochondrial energetics through mTORC1-independent PDH activation. Dev Cell. 2021;56(6):811-25.e6.","journal-title":"Dev Cell"},{"issue":"3","key":"3083_CR97","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK\/MAPK signalling pathway and tumorigenesis (Review). Exp Ther Med. 2020;19(3):1997\u20132007.","journal-title":"Exp Ther Med"},{"key":"3083_CR98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52511","volume":"9","author":"K Bogucka","year":"2020","unstructured":"Bogucka K, Pompaiah M, Marini F, Binder H, Harms G, Kaulich M, et al. ERK3\/MAPK6 controls IL-8 production and chemotaxis. Elife. 2020;9:e52511.","journal-title":"Elife"},{"issue":"10","key":"3083_CR99","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1080\/15548627.2018.1501251","volume":"14","author":"G Xu","year":"2018","unstructured":"Xu G, Li T, Chen J, Li C, Zhao H, Yao C, et al. Autosomal dominant retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced mitophagy through regulating ULK1 mrna splicing. Autophagy. 2018;14(10):1818\u201330.","journal-title":"Autophagy"},{"key":"3083_CR100","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2021.692948","volume":"15","author":"EC Rodrigues","year":"2021","unstructured":"Rodrigues EC, Grawenhoff J, Baumann SJ, Lorenzon N, Maurer SP. Mammalian neuronal mrna transport complexes: the few knowns and the many unknowns. Front Integr Neurosci. 2021;15: 692948.","journal-title":"Front Integr Neurosci"},{"issue":"1","key":"3083_CR101","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Qiu J, Zhang Z, Zhou L, Li Y, Ding D, et al. SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study. Cell Biosci. 2021;11(1):23.","journal-title":"Cell Biosci"},{"issue":"36","key":"3083_CR102","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1073\/pnas.0803055105","volume":"105","author":"A Lujambio","year":"2008","unstructured":"Lujambio A, Calin GA, Villanueva A, Ropero S, S\u00e1nchez-C\u00e9spedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci. 2008;105(36):13556\u201361.","journal-title":"Proc Natl Acad Sci"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03083-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:07:20Z","timestamp":1771600040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03083-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3083"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03083-3","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic review was conducted following the principles of the Declaration of Helsinki. Ethical approval for this review was obtained from the Hematology, Oncology, and Stem Cell Transplantation Research Center, Tehran. The ethical approval code for this study is IR.TUMS.HORCSCT.REC.1403.056.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}